This Washington Post article on "Gene therapy for rare form of blindness" is no longer online ...

Wow! https://t.co/2Zw389KmUC
— Ed Boyden (@eboyden3) December 20, 2017

https://twitter.com/eboyden3/status/943562176115097600

https://web.archive.org/web/20180101154157/http://a.abcnews.com/images/Health/WireAP_6040dce125954e01ae30d0061744b52f_16x9_992.jpg

https://web.archive.org/web/20180103224640/http://cdn.cnn.com/cnnnext/dam/assets/171220133414-02-fda-approves-luxturna-exlarge-169.jpg

*
Gene therapy for rare form of blindness
https://web.archive.org/web/20171222025508/https://www.washingtonpost.com/national/health-science/gene-therapy-for-rare-form-of-blindness-wins-us-approval/2017/12/19/3c40130a-e4de-11e7-927a-e72eac1e73b6_story.html

( https://www.washingtonpost.com/national/health-science/gene-therapy-for-rare-form-of-blindness-wins-us-approval/2017/12/19/3c40130a-e4de-11e7-927a-e72eac1e73b6_story.html )

Gene therapy for rare form of blindness wins US approval. ... The injection, called Luxturna, is the first gene therapy approved by the Food and Drug Administration in which a corrective gene is given directly to patients. The gene mutation interferes with the production of an enzyme needed for normal vision.Dec 19, 2017